SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001467154-23-000099
Filing Date
2023-09-07
Accepted
2023-09-07 16:58:48
Documents
14
Period of Report
2023-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20230831.htm   iXBRL 8-K 44825
2 EX-10.1 ex10-1xmaynexnovanxassetpu.htm EX-10.1 427484
3 EX-10.2 ex10-2xligandxnovanxamende.htm EX-10.2 495438
  Complete submission text file 0001467154-23-000099.txt   1264334

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20230831.xsd EX-101.SCH 1895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20230831_lab.xml EX-101.LAB 23834
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20230831_pre.xml EX-101.PRE 12504
8 EXTRACTED XBRL INSTANCE DOCUMENT novn-20230831_htm.xml XML 2708
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

IRS No.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 231242929
SIC: 2834 Pharmaceutical Preparations